1
Clinical Trials associated with Cancer vaccine(BlueWillow Biologics)An open-label, single-arm study evaluating the safety and efficacy of oral cancer vaccine B440 in PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer - oral cancer vaccine B440
Start Date19 Jan 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with Cancer vaccine(BlueWillow Biologics)
100 Translational Medicine associated with Cancer vaccine(BlueWillow Biologics)
100 Patents (Medical) associated with Cancer vaccine(BlueWillow Biologics)
100 Deals associated with Cancer vaccine(BlueWillow Biologics)